HENRY SCHEIN, INC. Proceeds from Sale of Interest in Corporate Unit
HENRY SCHEIN, INC. (HSIC) reported Proceeds from Sale of Interest in Corporate Unit of $0 for the 12-month period ending 2021-12-25, per its 10-K filed 2022-02-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfInterestInCorporateUnit · last filed 2022-02-15
- HENRY SCHEIN, INC. proceeds from sale of interest in corporate unit for the quarter ending 2020-12-26 was $0.00.
- HENRY SCHEIN, INC. proceeds from sale of interest in corporate unit for the quarter ending 2020-09-26 was $0.00.
- HENRY SCHEIN, INC. proceeds from sale of interest in corporate unit for the quarter ending 2020-06-27 was $0.00.
- HENRY SCHEIN, INC. proceeds from sale of interest in corporate unit for the quarter ending 2020-03-28 was $0.00, a 100.00% decline year-over-year.
- HENRY SCHEIN, INC. proceeds from sale of interest in corporate unit for fiscal 2021 was $0.00.
- HENRY SCHEIN, INC. proceeds from sale of interest in corporate unit for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- HENRY SCHEIN, INC. proceeds from sale of interest in corporate unit for fiscal 2019 was $1.12B.
- HENRY SCHEIN, INC. proceeds from sale of interest in corporate unit for fiscal 2018 was $0.00.
| Period end | Proceeds from Sale of Interest in Corporate Unit 3 month | Proceeds from Sale of Interest in Corporate Unit 6 month | Proceeds from Sale of Interest in Corporate Unit 9 month | Proceeds from Sale of Interest in Corporate Unit 12 month |
|---|---|---|---|---|
| 2021-12-25 | $0.00 10-K · filed 2022-02-15 | |||
| 2020-12-26 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $0.00 derived: sum of 2 quarters · filed 2022-02-15 | $0.00 derived: sum of 3 quarters · filed 2022-02-15 | $0.00 10-K · filed 2022-02-15 |
| 2020-09-26 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $0.00 derived: sum of 2 quarters · filed 2020-11-02 | $0.00 10-Q · filed 2020-11-02 | $0.00 derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-27 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $0.00 10-Q · filed 2020-08-04 | $0.00 derived: sum of 3 quarters · filed 2022-02-15 | $0.00 derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-28 | $0.00 10-Q · filed 2020-05-05 | $0.00 derived: sum of 2 quarters · filed 2022-02-15 | $0.00 derived: sum of 3 quarters · filed 2022-02-15 | $0.00 derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $0.00 derived: sum of 2 quarters · filed 2022-02-15 | $0.00 derived: sum of 3 quarters · filed 2022-02-15 | $1.12B 10-K · filed 2022-02-15 |
| 2019-09-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $0.00 derived: sum of 2 quarters · filed 2020-11-02 | $1.12B 10-Q · filed 2020-11-02 | $1.12B derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-06-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $1.12B 10-Q · filed 2020-08-04 | $1.12B derived: sum of 3 quarters · filed 2021-02-17 | $1.12B derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-03-30 | $1.12B 10-Q · filed 2020-05-05 | $1.12B derived: sum of 2 quarters · filed 2021-02-17 | $1.12B derived: sum of 3 quarters · filed 2021-02-17 | $1.12B derived: sum of 4 quarters · filed 2021-02-17 |
| 2018-12-29 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $0.00 derived: sum of 2 quarters · filed 2021-02-17 | $0.00 derived: sum of 3 quarters · filed 2021-02-17 | $0.00 10-K · filed 2021-02-17 |
| 2018-09-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $0.00 derived: sum of 2 quarters · filed 2019-11-05 | $0.00 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $0.00 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-07 | |||
| 2017-12-30 | $0.00 10-K · filed 2020-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/ (ACH) | United States | $0.057B | -0.87 |